Immutep Financials
| YP1B Stock | 0.19 0.02 11.76% |
Immutep |
Understanding current and past Immutep Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Immutep's financial statements are interrelated, with each one affecting the others. For example, an increase in Immutep's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Immutep's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Immutep. Check Immutep's Beneish M Score to see the likelihood of Immutep's management manipulating its earnings.
| Instrument | Germany Stock View All |
| Exchange | Stuttgart Exchange |
| ISIN | AU000000IMM6 |
| Benchmark | Dow Jones Industrial |
You should never invest in Immutep without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Immutep Stock, because this is throwing your money away. Analyzing the key information contained in Immutep's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Immutep Key Financial Ratios
Immutep's financial ratios allow both analysts and investors to convert raw data from Immutep's financial statements into concise, actionable information that can be used to evaluate the performance of Immutep over time and compare it to other companies across industries.Immutep Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Immutep's current stock value. Our valuation model uses many indicators to compare Immutep value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immutep competition to find correlations between indicators driving Immutep's intrinsic value. More Info.Immutep is rated below average in current valuation category among its peers. It is rated first in price to book category among its peers . The ratio of Current Valuation to Price To Book for Immutep is about 45,354,703 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Immutep's earnings, one of the primary drivers of an investment's value.Immutep Systematic Risk
Immutep's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Immutep volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Immutep correlated with the market. If Beta is less than 0 Immutep generally moves in the opposite direction as compared to the market. If Immutep Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Immutep is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Immutep is generally in the same direction as the market. If Beta > 1 Immutep moves generally in the same direction as, but more than the movement of the benchmark.
Immutep November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Immutep help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Immutep. We use our internally-developed statistical techniques to arrive at the intrinsic value of Immutep based on widely used predictive technical indicators. In general, we focus on analyzing Immutep Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Immutep's daily price indicators and compare them against related drivers.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 30.56 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 9.09 |
Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.